13,368 Addus HomeCare Corporation $ADUS Shares Sold by Summit Creek Advisors LLC

Summit Creek Advisors LLC lowered its position in Addus HomeCare Corporation (NASDAQ:ADUS) by 15.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 71,750 shares of the company’s stock after selling 13,368 shares during the quarter. Addus HomeCare comprises about 3.2% of Summit Creek Advisors LLC’s portfolio, making the stock its 2nd largest position. Summit Creek Advisors LLC owned 0.38% of Addus HomeCare worth $7,931,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Heritage Family Offices LLP purchased a new stake in Addus HomeCare in the 3rd quarter worth about $43,000. Bridge City Capital LLC boosted its position in shares of Addus HomeCare by 25.9% during the third quarter. Bridge City Capital LLC now owns 107,577 shares of the company’s stock valued at $11,892,000 after buying an additional 22,132 shares during the period. Vise Technologies Inc. purchased a new position in shares of Addus HomeCare during the third quarter valued at approximately $422,000. State of Wyoming boosted its position in shares of Addus HomeCare by 66.7% during the third quarter. State of Wyoming now owns 1,307 shares of the company’s stock valued at $144,000 after buying an additional 523 shares during the period. Finally, Smith Group Asset Management LLC grew its stake in shares of Addus HomeCare by 23.1% during the third quarter. Smith Group Asset Management LLC now owns 7,173 shares of the company’s stock valued at $793,000 after buying an additional 1,348 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Trading Down 2.0%

Shares of ADUS opened at $124.31 on Friday. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $131.59. The company has a 50-day moving average of $117.60 and a 200 day moving average of $106.88. The firm has a market capitalization of $2.32 billion, a price-to-earnings ratio of 20.72, a PEG ratio of 1.65 and a beta of 0.75. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.69.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.79 by $0.04. The company had revenue of $387.74 million during the quarter, compared to analysts’ expectations of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.56 EPS. On average, research analysts expect that Addus HomeCare Corporation will post 6.34 EPS for the current year.

Analysts Set New Price Targets

ADUS has been the topic of several recent analyst reports. Royal Bank Of Canada increased their price target on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Raymond James Financial set a $137.00 price objective on Addus HomeCare in a report on Monday, September 28th. Bank of America downgraded Addus HomeCare from a “buy” rating to a “neutral” rating and cut their price objective for the company from $140.00 to $125.00 in a research report on Monday, September 14th. UBS Group upped their price objective on Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday. Finally, TD Cowen increased their target price on Addus HomeCare from $131.00 to $145.00 and gave the stock a “buy” rating in a research note on Thursday. Seven research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $134.70.

Key Headlines Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: UBS raised its price target to $160 from $145 and maintained a Buy rating; TD Cowen lifted its target to $145 from $131 and also maintained a Buy rating. UBS price-target report TD Cowen price-target report
• Positive Sentiment: ADUS recently reached a 52-week high. Its latest quarterly results included earnings per share of $1.83, ahead of the $1.79 consensus, while revenue increased 7% year over year. Addus hits a 12-month high
• Positive Sentiment: The company said it expects to close its AccentCare acquisition in the first quarter of 2027 and anticipates a full-year adjusted EBITDA margin around 13%; the deal may offer a growth opportunity, though execution remains ahead. AccentCare update
• Neutral Sentiment: Recent Zacks pieces discuss ADUS’s momentum and value-investing appeal, but the available summaries do not provide specific ratings or new estimates. Zacks momentum article Zacks value article
• Negative Sentiment: Quarterly revenue of $387.74 million was slightly below analysts’ $388.72 million estimate, tempering the otherwise positive earnings beat. Q3 earnings call highlights

Addus HomeCare Company Profile

Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.